Vir Biotechnology (VIR) Stock Statistics & Valuation Metrics

Vir Biotechnology has a market cap or net worth of $1.61B. The enterprise value is $1.39B.

Vir Biotechnology has 168,651,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vir Biotechnology’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -50.94%.

The current PE Ratio of Vir Biotechnology is ―. Vir Biotechnology’s PEG ratio is 0.11.

In the last 12 months, Vir Biotechnology had revenue of 68.56M and earned -437.99M in profits. Earnings per share was -3.16.

In the last 12 months, operating cash flow was -446.05M and capital expenditures 1.24M, giving a free cash flow of -444.81M billion.

Vir Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Vir Biotechnology upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Vir Biotechnology as a current ratio of 5.54, with Debt / Equity ratio of 11.76%

In the past 12 months, Vir Biotechnology has paid 217.00K in taxes.

Vir Biotechnology EV to EBITDA ratio is -1.85, with an EV/FCF ratio of -1.99.

Vir Biotechnology has $472.36M in cash and marketable securities with $95.58M in debt, giving a net cash position of $376.78M billion.

Gross margin is 275.25%, with operating margin of -682.68%, and net profit margin of -638.87%.

The average price target for Vir Biotechnology is $21.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy